DESTINY-Breast T-DXd Brain Mets
Trastuzumab Deruxtecan for Brain Metastases in HER2-Positive Metastatic Breast Cancer: A Pooled Analysis of DESTINY-Breast01, 02, and 03 Trials

Released: November 01, 2023

Activity

Progress
1
Course Completed